Current Legal Status of 7OH in Canada As of 2026, 7OH (7-hydroxymitragynine) is not explicitly scheduled under the Controlled Drugs and Substances Act (CDSA) , meaning it is not federally classified as a controlled substance. However, its legal status can be complex and may vary by province or change over time. Purchases are generally limited to research and aromatherapy purposes, and Health Canada prohibits any medicinal claims or therapeutic use , so compliance with these r

Table of Contents Scientific and Historical Context Defining 7-Hydroxymitragynine Chemical Structure and Classification Structural Comparison Overview Mitragynine vs 7OH Detection Methods and Lab Analysis Research Classification Standards Regulatory Considerations in Canada Laboratory Applications Stability and Storage Reporting Standards FAQ Disclaimer Introduction Interest in 7-hydroxymitragynine (7OH) has grown among Canadian researchers and laboratory professionals due to

Overview 7-hydroxymitragynine (7OH) is typically examined in controlled laboratory environments where accurate identification, structural validation, and purity assessment are essential. Because of its close similarity to mitragynine and other indole alkaloids, distinguishing it requires advanced instrumentation, validated analytical procedures, and reliable reference standards. To ensure consistent and accurate results, laboratories rely on precise calibration, standardized

As interest in advanced alkaloid research continues to grow across Canada, laboratories and research teams are increasingly seeking reliable, consistent sources of 7-hydroxymitragynine (7OH). With evolving analytical standards and stricter expectations around compound verification, the need for high-quality reference materials has never been greater. Designed specifically to support structured laboratory environments, 7OHyea provides calibrated, research-grade 7OH tablet form